Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
about
Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysisManagement of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalGenome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.Developmental Stage-Specific Embryonic Induction of HepG2 Cell Differentiation.
P2860
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@en
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@nl
type
label
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@en
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@nl
prefLabel
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@en
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@nl
P2093
P2860
P1476
Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
@en
P2093
Changlai Zhu
Tianyi Zhang
Xiaodong Huang
Xinxiu Wang
P2860
P2888
P304
P356
10.1007/S10620-013-2969-2
P577
2013-12-25T00:00:00Z